A nationwide recall of nearly 90,000 bottles of children’s ibuprofen is raising concerns as families head into the summer cold and flu season, a time when many rely on over-the-counter medications to manage fevers and discomfort.
The recall involves Children’s Ibuprofen Oral Suspension, a 100-milligram per 5-milliliter liquid sold in 4-fluid-ounce bottles. Federal health officials report that some bottles may contain a foreign substance, including a gel-like mass and black particles.
The affected products were manufactured in India by Strides Pharma Inc., which operates a U.S.-based division, for Taro Pharmaceuticals USA Inc., and were distributed nationwide.
The recall includes lot numbers 7261973A and 7261974A, both with an expiration date of January 31, 2027. The recall number is D-0390-2026.
The medication was sold through retail stores and pharmacies across the United States. Officials have not released a specific list of retailers, so consumers are urged to check the lot numbers on any children’s ibuprofen they have at home.
The U.S. Food and Drug Administration has classified the recall as Class II, meaning use of the product could cause temporary or medically reversible health issues, while the likelihood of serious harm is considered low. At this time, no serious adverse health effects have been reported.
Health officials are urging parents and caregivers to check their medicine cabinets and stop using any recalled products immediately. Because liquid medications must be consistent and free of contaminants to ensure safe and accurate dosing, the presence of foreign material poses a potential risk, especially for children.
With summer illnesses already circulating, families are encouraged to verify the safety of medications before use and to consult a healthcare provider if a child experiences any unusual symptoms after taking ibuprofen.
